| July 1 |
ADVENTRX Announces Preliminary Response Rate Data From Discontinued
Phase 3 Trial of CoFactor |
| July 1 |
Halozyme Therapeutics Announces That Chemophase Meets Primary
Endpoint in Phase I/IIa Clinical Trial |
| July 1 |
Burnham Institute Researchers Link Early Stem Cell Mutation to
Autism |
| July 1 |
Bad News to Bad Bugs: Northern Antibiotics Develops Novel
Polymyxins With Reduced Toxicity |
| July 1 |
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3
Trial of Dacogen Versus Supportive Care in Patients With
Myelodysplastic Syndromes |
| July 1 |
Journal of Clinical Oncology Publishes Leukine Study Demonstrating
Positive Survival Outcomes in Patients with High-Risk Melanoma |
| July 1 |
Cancer Cells Revert to Normal at Specific Signal Threshold,
Stanford Researchers Find |
| July 1 |
Results Published in the Journal 'Cancer' Demonstrate that Oral
Talactoferrin Alfa is Active as Monotherapy in Previously Treated
Patients with Metastatic Renal Cell Carcinoma |
| July 1 |
Oculus Innovative Sciences Announces Positive Results from Abstract
Evaluating the Use of Microcyn(R) Technology in Treatment of Atopic
Dermatitis |
| July 1 |
Alkermes Presents Positive Data on Proprietary Molecules Targeting
Opioid Receptors |
| July 1 |
Yeast-Based Vaccine Induces Immune Responses and Reduces Tumor Size
in Mice |
| July 1 |
arGentis Files Patent on Nucleic Acid Sequences and Polymorphisms
Predictive of Patient Responses to ARG201 an Immunotherapy for Late
Phase Systemic Sclerosis |
| July 1 |
'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly
Improves Survival After Extreme Blood Loss |
| July 1 |
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial
of Dacogen Versus Supportive Care in Patients With Myelodysplastic
Syndromes |
| July 1 |
Pediatric Researchers Find Possible 'Master Switch' Gene in
Juvenile Arthritis |
| July 1 |
Since Introduction of Highly Active Antiretroviral Therapy, Death
Rate for HIV-infected Persons Has Decreased |
| July 2 |
Titan Pharmaceuticals Announces Spheramine Initial Phase IIb
Results |
| July 2 |
ExonHit Presents Therapeutic and Diagnostic Programs for
Alzheimer's at ICAD 2008 |
| July 2 |
Lorus Therapeutics Announces Publication of a Clinical Study
Demonstrating Encouraging Results with LOR-2040 in Combination with
Cytarabine in Patients with Acute Myeloid Leukemia (AML) |
| July 2 |
FDA Updates Atripla Package Insert |
| July 2 |
MicroIslet Provides Safety and Efficacy Data Update |
| July 2 |
Peregrine Pharmaceuticals Reports Positive Early Results in Phase
II Study of Bavituximab in Breast Cancer |
| July 2 |
Controlling Bone Disease Improves Survival of Hemodialysis Patients |
| July 3 |
ARYx Therapeutics, Inc. Announces Successful Results of QT Study on
ATI-7505 |
| July 3 |
New Research Indicates That Adrenal Nodules Not Being Adequately
Evaluated |
| July 3 |
Vavelta: Phase II Data Presented at Face and Commercial Sales
Commenced |
| July 3 |
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing
Resolvins Suppress IL-23 and IL-17, Key Mediators of Inflammatory
Disease |
| July 3 |
Evotec's EVT 101 Well Tolerated in Four Week Higher Repeat Dose
Safety Study |
| July 3 |
Blood Vessel Inhibitor Shows Promise Against Metastatic Thyroid
Cancer Researchers Also Find Evidence Tying a Genetic Mutation to
Clinical Outcome |
| July 3 |
Phase III ARISER Study with Rencarex: Patient Recruitment
Successfully Completed |
| July 3 |
Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss
Top-Line Phase 2 Study Results in Huntington's Disease |
| July 7 |
Teva Provides Update on Forte Trial |
| July 7 |
Complete Study Results Comparing CTI's Opaxio With Gemcitabine or
Vinorelbine in Performance Status (PS 2) NSCLC Patients Published
in Journal of Thoracic Oncology |
| July 7 |
BrainStorm Cell Therapeutics and Rutgers University Study Shows
That Transplanting NTF Cells Improves the Recovery of Spinal Cord
Injury Rat Model |
| July 7 |
Early Findings Show Promise as AS1411 AML Study Proceeds to
Higher-dose Stage |
| July 7 |
Suven Life Sciences Clinical candidate SUVN-502 Being Presented at
International Conference on Alzheimer’s Disease, ICAD-2008 at
Chicago, USA |
| July 7 |
Advitech Announces Positive Clinical and Pre-Clinical Results |
| July 7 |
Probiodrug to Present Novel Causative Treatment Approach for
Alzheimer’s Disease QC Inhibition To Be Discussed at
Alzheimer's Association International Conference on Alzheimer's
Disease (ICAD) 2008 |
| July 7 |
ReGen Biologics Announces JBJS Publication of Successful Clinical
Trial Results for its Meniscus Product |
| July 7 |
Xclair Reported to Be Safe and Effective in Study Published in
European Journal of Dermatology |
| July 7 |
New Treatment Strategy Can Beat Depression in Cancer Patients
(SMaRT Oncology 1 Trial) |
| July 7 |
Gender is an Issue in Kidney Transplantation |
| July 7 |
New Drugs for Crohn’s Disease |
| July 7 |
Kidney Cancer Patients Given Vaccine Show No Increased Survival |
| July 7 |
GeoVax Reports Progress on Its AIDS Vaccine Technology |
| July 7 |
Data Presented at Annual Meeting of Japanese Society of
Interventional Cardiology Demonstrate OrbusNeich's Genous
Bio-engineered R Stent Has Better Outcomes When Compared to
Drug-Eluting Stents |
| July 7 |
Embryo Viability Studies Support Utility of Novel, Metabolomic
Profiling Technology |
| July 7 |
St. Jude Study Reveals a New Function for an Old Enzyme in Fatal
Childhood Disease |
| July 7 |
Patients More Likely to Stay on Lipitor Than Simvastatin, a Large
Observational Study Shows |
| July 8 |
Medivation Announces Positive Top-Line Results From Phase 2 Dimebon
Study in Huntington's Disease |
| July 8 |
New study reveals Caduet two-in-one pill dramatically improves
patient adherence |
| July 8 |
LifeCycle Pharma Announces Positive Topline Results from Phase II
Clinical Study of LCP-Tacro Once Daily in Stable Liver Transplant
Patients |
| July 8 |
Some Antidepressants Associated with Gastrointestinal Bleeding |
| July 8 |
Head-to-Head Study Demonstrates Focalin XR Offers Faster and Better
Symptom Control than Concerta in Early Part of ADHD Patients' Day |
| July 8 |
Sciele Pharma Completes Phase III Safety Trial for Glycopyrrolate
Liquid, a Treatment for Chronic, Moderate-to-Severe Drooling in
Pediatric Patients |
| July 8 |
Emisphere Announces Data From Independent Clinical Study of Effects
of Oral GLP-1 on Glucose and Insulin Concentrations |
| July 8 |
Study Measures Real-World Comparative Effectiveness of Asthma
Controller Medications |
| July 8 |
Schering-Plough Announces Phase III Data for Sustained Follicle
Stimulant |
| July 8 |
Introgen to Host Conference Call with Clinical Investigators to
Discuss Phase III Data and Advexin Registration Activities |
| July 9 |
Androgen Deprivation Therapy for Localized Prostate Cancer Not
Associated with Improved Survival |
| July 9 |
Welichem Succesfully Completes Phase I Clinical Trial |
| July 9 |
Lorus Therapeutics Provides an Update on Progress in Virulizin
Development Program |
| July 9 |
Compugen Announces Positive In-Vivo Results for Therapeutic Peptide
Candidate for Immune Related Diseases |
| July 9 |
Polyphor Successfully Completes Phase I Clinical Trials of POL6326 |
| July 9 |
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial
Results of APD791 for the Treatment of Arterial Thrombosis |
| July 9 |
Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial
Results of APD791 for the Treatment of Arterial Thrombosis |
| July 9 |
Icagen Successfully Completes Phase I Multiple Ascending Dose
Clinical Trial of Senicapoc |
| July 9 |
Aradigm to Hold Business Update Conference Call on July 16 |
| July 9 |
Kidney Disease Linked to Lower Medication Use After Heart Attack |
| July 10 |
CYT003-QbG10 Monotherapy for the Treatment of Allergic Diseases is
Safe and Efficacious in Placebo-controlled Phase II Study |
| July 10 |
Sosei Announces Completion of Phase III Trial for NorLevo |
| July 10 |
Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics
Congress in Budapest, Hungary |
| July 10 |
Prostate Cancer Vaccines more Effective with Hormone Therapy |
| July 10 |
Novel Approach May Protect Against Heart Attack Injury |
| July 10 |
Common Mechanisms May Underlie Autism's Seemingly Diverse Mutations |
| July 11 |
Mesoblast Limited Announce Pre-clinical Trials Show Allogenic Stem
Cells Effectively Treat Eye Diseases |
| July 11 |
Repros Therapeutics Inc. Announces That Proellex Significantly
Reduces Pain in a U.S. Phase 2 Clinical Trial in Women with
Moderate to Severe Endometriosis |
| July 11 |
Pharming Announces Positive Results From Rhucin Open-label
Clinicial Studies |
| July 11 |
Neuron to Publish Prana's PBT2 Preclinical Research |
| July 11 |
Mesoblast Limited (ASX:MSB) Announce Pre-clinical Trials Show
Allogenic Stem Cells Effectively Treat Eye Diseases |
| July 11 |
Oxford BioMedica Announces Data Safety Monitoring Board
Recommendation for Trovax PHASE III Trist Study |
| July 14 |
Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and
Herceptin in Journal Clinical Cancer Research |
| July 14 |
Cardiome to Hold Conference Call |
| July 14 |
ADAGIO Phase III Top Line Data to be Presented at 12th Congress of
European Federation of Neurological Societies |
| July 14 |
Eight-Year Melanoma Remission is Among Early Cancer Treatment
Results |
| July 14 |
Vical to Present Phase 1 Data for Vaxfectin-Formulated Pandemic
Influenza DNA Vaccines |
| July 14 |
Pegylated Interferon Alfa-2b Improves Recurrence-free Survival in
Melanoma Patients |
| July 14 |
Now More Than Ever, Improved TB Vaccines Urgently Needed |
| July 14 |
Preventive Malaria Treatment Lowers Anaemia Prevalence and Improves
Attention Span of School Children |
| July 14 |
NanoViricide's EKC Eye Drug Candidate Stopped Clinical
Conjunctivitis Pathology |
| July 14 |
New Publication Shows Cleviprex is Effective for Rapid Treatment of
Acute Hypertension After Cardiac Surgery |
| July 14 |
Cardiome Announces Positive Phase 2b Results For Oral Vernakalant |
| July 14 |
Amgen Announces Positive Top-Line Results for Denosumab Treatment
of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing
Androgen Deprivation Therapy |
| July 14 |
Amgen Announces Positive Top-Line Results for Denosumab Treatment
of Bone Loss in Men With Non-Metastatic Prostate Cancer Undergoing
Androgen Deprivation Therapy |
| July 14 |
Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III
Melanoma Demonstrated Significant and Sustained Impact on
Relapse-Free Survival |
| July 14 |
Alkermes Presents Positive Preclinical Data on Naltrexone for
Extended-Release Injectable Suspension at Annual Meeting of
Controlled Release Society |
| July 14 |
Pfizer to Showcase Alzheimer's Research and Pipeline at Upcoming
Alzheimer's Disease Medical Meeting |
| July 14 |
Genaera Corporation Presents Data on Mechanism of Inhibition of
PTP-1B for Trodusquemine (MSI-1436) at Federation of American
Societies for Experimental Biology (FASEB) Meeting |
| July 15 |
Theravance Announces Positive Phase 2 Clinical Results in the MABA
Respiratory Program for the Treatment of COPD |
| July 15 |
XOMA 052 Phase 1 Data to be Presented At European Association for
the Study of Diabetes Annual Meeting |
| July 15 |
New Survey Findings Reveal Emotional and Physical Toll of
Rheumatoid Arthritis and the Advancement of Treatment Through
'Generations' |
| July 15 |
Study Examines Anti-clotting Therapy Following Cardioembolic Stroke |
| July 15 |
Cardiome Announces Positive Phase 2b Results For Oral Vernakalant |
| July 15 |
Journal of Clinical Oncology Publishes Study of Cephalon Medication
Treanda Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma |
| July 15 |
IRX Therapeutics to Present Phase 2 Results at 7th International
Conference on Head and Neck Cancer |
| July 16 |
Study Showed Half of Patients Treated with Enbrel (etanercept) Plus
Methotrexate Can Achieve DAS Clinical Remission and 80 Percent Had
No Progression of Joint Damage in Active Early Rheumatoid Arthritis |
| July 16 |
Vitamin K deficiency may be a significant risk factor for low bone
mass in healthy children and in those with juvenile arthritis |
| July 16 |
MAP Pharmaceuticals Announces Publication of MAP0004 Study in
Current Medical Research and Opinion |
| July 16 |
Inovio Biomedical's First Proprietary DNA Vaccine Achieves 100%
Protection Against Avian Flu in Pre-Clinical Testing |
| July 16 |
Statin Does Not Appear Helpful for Children with Learning
Disabilities Caused by Genetic Disorder |
| July 16 |
Optimer Pharmaceuticals Announces Positive Results in Prulifloxacin
Phase 3 Study |
| July 16 |
MIV Provides Update on Its Next-Generation, Ultra-Thin Protea Stent
Platform |
| July 16 |
Researchers Discover Link Between Organ Transplantation and
Increased Cancer Risk |
| July 16 |
URGENT Study Provides Important New Insight into the Use of Dyspnea
as a Clinical Endpoint for Evaluating New Treatments for Acute
Heart Failure Syndromes |
| July 16 |
Insightful Corporation Announces Webinar on "Graphical Evaluation
for Cardiovascular Safety Data in Clinical Trials" |
| July 16 |
MaxCyte to Present Scalable Clinical and Commercial Manufacturing
Technology for Cell-based and Viral-based Vaccines |
| July 17 |
Biojector 2000 Data Presented in Vical's Pandemic Influenza DNA
Vaccine Human Trial |
| July 17 |
Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines
With Preliminary Human Data |
| July 17 |
Introgen to Present ADVEXIN Phase 3 Study Results at American
Association for Cancer Research's Cancer Clinical Trials and
Personalized Medicine Conference |
| July 17 |
Bradmer Reports Progression Free Survival Data from Previous Phase
II Glioblastoma Multiforme Trials |
| July 17 |
Repros Therapeutics Inc. Announces That Proellex Administered to
Patients as Cyclic Therapy to Treat the Symptoms of Uterine
Fibroids for Up to 30 Months Shows No Adverse Effects on the
Endometrium |
| July 17 |
Published Study Demonstrates Lower Serum Creatinine Levels after
Contrast Media Administration with Iodixanol Than with Iopromide |
| July 17 |
BioNumerik Pharmaceuticals Observes Evidence of a Survival Increase
in Lung Cancer Patients Participating in Tavocept Clinical Trial |
| July 17 |
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and
the Release of EASD Abstracts Containing Additional Interim Data
From Its VIAject Program |
| July 17 |
Advanced Life Sciences Announces Collaboration With UK Ministry of
Defence on ALS-886 |
| July 17 |
Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII
International AIDS Conference |
| July 17 |
Biovest Reports Results for Patients Treated with Anti-Cancer
Vaccine: BiovaxID Demonstrates Clinically and Statistically
Significant Improvement of Disease-Free Survival in Non-Hodgkin's
Lymphoma in Pivotal Phase 3 Clinical Trial |
| July 17 |
Nemours Center for Childhood Cancer Research Team at the Alfred I.
duPont Hospital for Children Identifies the Function of a Biomarker
Present in Prostate Cancer Cells: New Insight into Therapeutic
Benefit for Patients with Advanced Prostate Cancer |
| July 18 |
Medivation Announces Publication in The Lancet of Dimebon Pivotal
Trial Results in Alzheimer's Disease |
| July 18 |
Resverlogix's Lead Drug Featured in Key Scientific Publication |
| July 18 |
Repros Therapeutics Inc. Announces That Initial Findings for
Proellex Show No Tumorigenic Response in a Two-year Carcinogenicity
Study in Rats |
| July 21 |
NSL-043 Achieves Success in Phase I Multiple Ascending Dose Trial |
| July 21 |
Repros Therapeutics Inc. Announces That the Results of the European
Trial Demonstrating Uterine Fibroid Size Reduction in Patients
Administered Proellex(R) Will Be in Print in August 2008 |
| July 21 |
Verto, a Subsidiary of Hadasit Bio-Holdings, Completes Successful
Human Clinical Trial of a Treatment for Lupus |
| July 21 |
Update on the SEAS Study |
| July 21 |
Results From the SEAS (Simvastatin and Ezetimibe in Aortic
Stenosis) Study |
| July 21 |
Paper in Molecular Cancer Therapeutics Reports that a Novel
Combination of Alfacell's Onconase and Rosiglitazone Induces a
Synergistic Apoptotic Effect in Several Cancer Cell Lines |
| July 21 |
Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of
Ezetimibe |
| July 21 |
High Hopes for New Treatments at Fragile X International Conference |
| July 22 |
Elan and Wyeth Announce Webcast to Discuss Bapineuzumab Phase 2 Clinical Trial Results |
| July 22 |
Plants Make Vaccine for Treating Type of Cancer in Stanford Study |
| July 22 |
Opexa Conducts Additional Analysis on Phase I/II Extension Study with Tovaxin for Multiple Sclerosis |
| July 22 |
Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models |
| July 22 |
Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes |
| July 22 |
Claire SkyePharma Announces Positive Results for Two European Studies for Flutiform |
| July 22 |
New Paper Published in "Stem Cells" Reporting In-Vivo Migration Ability of Brainstorm Cell Therapeutics' NTF Cells |
| July 22 |
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer |
| July 22 |
Epilepsy Drug May Increase Risk of Birth Defects |
| July 22 |
Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus |
| July 22 |
BTG plc: Study Shows Abiraterone Can Successfully Treat Aggressive, Chemotherapy-Resistant Prostate Cancer |
| July 22 |
BioNeutral Confirms Broad Spectrum Efficacy with Its Ygiene Antimicrobial |
| July 22 |
Verto, a Subsidiary of Hadasit Bio-Holdings, Completes Successful Human Clinical Trial of a Treatment for Lupus |
| July 22 |
Experts Available to Discuss Study on Silent Strokes |
| July 22 |
IRX Therapeutics Announces Results of Phase 2 Study for IRX-2 |
| July 22 |
YM Biosciences Presents Data Comparing Mechanism of Action for EGFR Antibody, Nimotuzumab to Cetuximab and Panitumumab, at the Aacr Centennial Conference on Translational Cancer Medicine 2008 |
| July 22 |
Once Suspect Protein Found to Promote DNA Repair, Prevent Cancer |
| July 22 |
New Study Shows Drug Combats Previously Untreatable Prostate Cancers |
| July 22 |
Helicon Study of HT-0712 on Primate Memory Formation Reveals Significant Enhancement |
| July 23 |
ZIOPHARM Presents Safety and Preliminary Efficacy Data from Two Phase I Studies of Indibulin at AACR Centennial Conference |
| July 23 |
Advexin Shows Statistically Significant Six-Month and Overall Survival Benefit as Compared to Methotrexate in Prospectively Defined Biomarker Patient Population |
| July 23 |
Use of Sildenafil Associated with Improvement in Antidepressant-related Sexual Dysfunction in Women |
| July 23 |
FluoroPharma Announces Positive Phase I Safety Results for BFPET, Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) |
| July 23 |
SWCRF Researcher Identifies Ways to Significantly Expand the Applicability of a Unique Anti-Cancer Drug |
| July 23 |
InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| July 23 |
Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs |
| July 24 |
NEJM Publishes Nexavar Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer |
| July 24 |
NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension |
| July 24 |
Isentress (raltegravir), Merck's First in Class Integrase Inhibitor, Suppressed HIV-1 Viral Load and Increased CD4 Cell Counts through 48-Weeks in Treatment-Experienced Adult Patients When Taken with Other Anti-HIV Medicines |
| July 24 |
Biodel Announces Publications Demonstrating Superior Metabolic Profile of VIAject Compared to the Rapid-acting Analog Humalog and Regular Human Insulin in Healthy Volunteers and Compared to Regular Human Insulin in Patients with Type 1 Diabetes |
| July 24 |
MacroChem Announces Phase 2 Data for EcoNail in the Treatment of Onychomycosis |
| July 24 |
'Statins' Linked to Improved Survival in Kidney Transplant Recipients |
| July 24 |
Alizyme Announces Headline Results from Its European Phase III Clinical Trial of Colal-Pred in Patients with Moderate to Severe Ulcerative Colitis |
| July 24 |
Webcast Alert: JAMA Media Briefing on HIV/AIDS |
| July 24 |
Cancer Treatment Application of the Aethlon Hemopurifier Published in Journal of Translational Medicine |
| July 24 |
Studies Assessed by European Health Authority Conclude That Impurity in Roche’s Viracept (nelfinavir Mesylate) Did Not Increase Patients’ Risk of Cancer |
| July 25 |
Journal of Clinical Oncology Article Highlights CellSearch Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer |
| July 25 |
Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit |
| July 25 |
Study Confirms that Levitra on Demand is Effective in Patients with ED after Nerve-sparing Prostatectomy |
| July 25 |
BG Medicine Announces Publication of Biomarker Signature of Atherosclerotic Plaque Rupture |
| July 25 |
Prana Biotechnology Announces Conference Call Following ICAD Presentation - July 31, 2008 at noon EDT (USA) |
| July 28 |
Nventa Announces Final Data from HspE7 Phase 1 Cervical Dysplasia Trial |
| July 28 |
BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting |
| July 28 |
Exforge Helps Nearly Twice as Many Patients Control Their High Blood Pressure Compared to Amlodipine Alone |
| July 28 |
Amgen Announces Positive Top-Line Results for Denosumab Pivotal Postmenopausal Osteoporosis Trial |
| July 28 |
New Research on Pre-Eclampsia in Mice May Have Important Implications for Humans |
| July 28 |
Head-to-head Study Results Demonstrated No Significant Difference Between NicoDerm CQ and Chantix (Varenicline Tartrate) in Long Term Quit Rates |
| July 28 |
InCode BioPharmaceutics, Inc. Announces Key Safety Data for rC3-1: A New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| July 28 |
Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets |
| July 29 |
Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting |
| July 29 |
Inspire Provides Update on Cystic Fibrosis Clinical Program |
| July 29 |
Valens Pharma Reports Top-Line Results from Voluntary Phase II Trial |
| July 29 |
Tumor Targeting Docetaxel Abstract Presented at the 11th Liposome Research Days Conference |
| July 29 |
OctoPlus Proves Efficacy of OP-145 in Phase II Ear Infection Study |
| July 29 |
Titan Pharm Announces Positive Ph 3 Probuphine Opioid Addiction Treatment Results |
| July 29 |
Discovery Labs KL-4 Surfactant Anti-Inflammatory Data Published in Pediatric Research |
| July 29 |
Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention |
| July 29 |
Older Treatment May be More Effective in Preserving Sight For Some Patients With Diabetes |
| July 30 |
High Statin Doses Do Not Impair Aerobic Activity or Skeletal Muscle Function in Older Adults, Says New Study |
| July 30 |
Preliminary Cerepro Phase III Results Meet Primary Endpoint |
| July 30 |
Acorda Therapeutics Presents Positive Data from Preclinical Studies of Neuregulins in Cardiac Function |
| July 30 |
Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimer's |
| July 30 |
Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer`s Disease |
| July 30 |
Four Alzheimer's Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation |
| July 30 |
Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success |
| July 30 |
Early Study Reveals New Drug Could Improve Executive Function in Alzheimer's Patients |
| July 30 |
Elan and Wyeth Present Encouraging Results from Phase 2 Clinical Trial of Bapineuzumab at International Conference on Alzheimer's Disease |
| July 30 |
Laboratory and Mouse Studies Show Targeted Drug Blocks the Growth of Breast Cancer Cells that Spread to the Brain |
| July 30 |
New Data Highlight Positive Results of Namenda (memantine HCl) Once-Daily Extended-Release Formulation |
| July 30 |
Published Study Shows Oxycyte Successfully Reduces Oxygen Shortages in a Spinal Cord Injury Model |
| July 30 |
First Ever Study on Alzheimer's Disease Treatment in Hispanics Presented at Major Medical Meeting |
| July 30 |
Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease |
| July 30 |
Alzheimer's Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors |
| July 31 |
Phase II Data on Lilly's Antibody Show it Affects Amyloid Beta, a Protein Believed to be Associated with Alzheimer's Disease |
| July 31 |
Lifestyle Factors Contribute to Lowering and Raising Risk of Alzheimer's Disease |
| July 31 |
Diverse Approaches to Alzheimer's Therapies Continue to Show Progress at ICAD |
| July 31 |
Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials |
| July 31 |
Memory Pharmaceuticals Presents Positive Preclinical Data for MEM 68626 at ICAD 2008 |
| July 31 |
Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the International Conference on Alzheimer's Disease |
| July 31 |
Medivation Presents Positive New Data on Dimebon's Long-Term Efficacy and Novel Mechanism of Action at the Interantional Conference on Alzheimer's Disease |
| July 31 |
Anavex Presents Neuroprotective Effects of ANAVEX 1-41 at the International Conference on Alzheimer's Disease 2008 |
| July 31 |
Micro RNA Implicated as Molecular Factor in Alcohol Tolerance |
| July 31 |
Mechanism for Postpartum Depression Found in Mice Discovery May Lead to Better Treatments |
| July 31 |
Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study |
| July 31 |
Treatment Corrects Severe Insulin Imbalance in Animal Studies |
